OOIR: Observatory of International Research

Papers

(The TQCC of Current Rheumatology Reports is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Kawasaki Disease: an Update	138
COVID-19 and Myositis: What We Know So Far	92
A Review of Complement Activation in SLE	69
Systemic Lupus Erythematosus in Children and Young People	61
New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO	58
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences	55
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease	54
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update	53
Epidemiology of Antiphospholipid Syndrome in the General Population	51
Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis	50
Update on Imaging-Based Measurement of Bone Mineral Density and Quality	44
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides	42
Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities	41
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention	37
The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency	36
New Criteria for Lupus	36
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease	33
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope	32
The Use of COVID-19 Vaccines in Patients with SLE	31
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component	31
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments	31
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics	30
NETs in APS: Current Knowledge and Future Perspectives	30
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?	29
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	28

Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	28
Work Disability in Axial Spondyloarthritis	26
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa	26
The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum	26
How to Interpret Antiphospholipid Laboratory Tests	25
Lupus Vasculitis	24
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides	24
Imaging in Vasculitis	24
Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials	23
Advances in the Treatment of Behcet’s Disease	23
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis	23
Reactive Arthritis: Treatment Challenges and Future Perspectives	22
Management of Non-criteria Manifestations in Antiphospholipid Syndrome	22
Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain	22
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria	22
Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis	21
An Update on the Diagnosis and Management of Lupus Nephritis	21
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention	21
Pregnancy Outcomes in Systemic Vasculitides	20
An Update on Antiphospholipid Syndrome	20
MicroRNAs in Systemic Lupus Erythematosus: a Perspective on the Path from Biological Discoveries to Clinical Practice	20
Treatment of Axial Spondyloarthritis: What Does the Future Hold?	20
Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management	20
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis	19
Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future	19
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies	19
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs	19
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?	19
Gut Microbiota in Lupus: a Butterfly Effect?	19
SARS-CoV-2 and Systemic Lupus Erythematosus	18
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus	18
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis	18
Metabolic Regulation of Tendon Inflammation and Healing Following Injury	18
Hyperuricemia, Gout, and the Brain—an Update	17
Axial Psoriatic Arthritis	16
The Role of Antiphospholipid Antibodies in COVID-19	16
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	16
Vasculitides in HIV Infection	16
Acupuncture and Chronic Musculoskeletal Pain	16
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)	16
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist	16